我国麻醉药品和精神药品行政监管法规完善建议  

Suggestions on Improvement ofAdministrative Regulations on Narcotic Drugs and Psychotropic Drugs in China

作　　者：樊莹莹[1] 齐莹莹 穆星佳 王晨慧 姜庆丹[1] 乔明娟 FAN Ying-ying;QI Ying-ying;MU Xing-jia;WANG Chen-hui;JIANG Qing-dan;QIAO Ming-juan(College of Postgraduate,Liaoning University of Traditional Chinese Medicine,Liaoning Shenyang 110847,China;Licheng District People's Court,Jinan,Shandong Jinan 250014,China;Shandong Huayu University of Technology,Shandong Dezhou 253034,China)

机构地区：[1]辽宁中医药大学研究生学院,辽宁沈阳10847 [2]济南市历城区人民法院,山东济南250014 [3]山东华宇工学院,山东德州253034

出　　处：《中国药物警戒》2018年第1期28-31,共4页Chinese Journal of Pharmacovigilance

摘　　要：目的分析自《中华人民共和国药品管理法》颁布实施以来,我国麻醉药品和精神药品(简称"麻精药品")行政监管法规体系的现状,探索实践中麻精药品法律法规体系凸显的不足和缺陷,并提出完善建议。方法检索分析大量文献,整理麻精药品的行政监管立法沿革,探索麻精药品监管法规体系的不足和缺陷。结果麻精药品行政监管法规存在的不足与缺陷,不能有效满足多元复杂的行政执法活动。结论建议及时分析行政法规体系不足与缺陷,完善行政法规,提高麻精药品的行政监管水平。Objective To analyze the status of the administrative supervision and regulation system of narcotic drugs and psychotropic drugs(hereinafter referred to as"the two drugs")in our country since the promulgation and implementation of the Drug Administration Law of the People's Republic of China,so as to explore the shortcomings and deficiencies in the laws and regulations in practice and propose suggestions.Methods A large number of documents were searched and analyzed,legislative evolution of administrative supervision were collected and arranged,The shortcomings and deficiencies of the regulation system were explored.Results The shortcomings and deficiencies in the laws and regulations of administrative supervision could not effectively meet the needs of multiple and complex administrative law enforcement activities.Conclusion It is suggested to analyze the shortcomings and deficiencies of administrative laws and regulations in time,perfect the administrative regulations and improve the administrative supervisioan.

关 键 词：麻醉药品 精神药品 法规 完善建议 

分 类 号：R951[医药卫生—药学]